StageZero Life Sciences Announces Closing of CAD$1.87 Million Private Placement with Institutional Investor
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / March 3, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and …
Weiterlesen »